- Home
- AES vs BAX Comparison
AES vs BAX Comparison
Compare AES & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AES
- BAX
- Stock Information
- Founded
- AES 1981
- BAX 1931
- Country
- AES United States
- BAX United States
- Employees
- AES N/A
- BAX N/A
- Industry
- AES Electric Utilities: Central
- BAX Medical/Dental Instruments
- Sector
- AES Utilities
- BAX Health Care
- Exchange
- AES Nasdaq
- BAX Nasdaq
- Market Cap
- AES 9.6B
- BAX 9.2B
- IPO Year
- AES 1991
- BAX N/A
- Fundamental
- Price
- AES $13.69
- BAX $18.38
- Analyst Decision
- AES Buy
- BAX Hold
- Analyst Count
- AES 10
- BAX 10
- Target Price
- AES $15.44
- BAX $27.00
- AVG Volume (30 Days)
- AES 9.3M
- BAX 10.0M
- Earning Date
- AES 11-04-2025
- BAX 10-30-2025
- Dividend Yield
- AES 5.21%
- BAX 0.23%
- EPS Growth
- AES N/A
- BAX N/A
- EPS
- AES 1.46
- BAX N/A
- Revenue
- AES $12,094,000,000.00
- BAX $11,023,000,000.00
- Revenue This Year
- AES $1.04
- BAX $5.72
- Revenue Next Year
- AES $4.54
- BAX $2.52
- P/E Ratio
- AES $9.07
- BAX N/A
- Revenue Growth
- AES N/A
- BAX 3.90
- 52 Week Low
- AES $9.46
- BAX $17.40
- 52 Week High
- AES $15.51
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- AES 44.98
- BAX 39.69
- Support Level
- AES $13.61
- BAX $17.40
- Resistance Level
- AES $14.11
- BAX $18.92
- Average True Range (ATR)
- AES 0.52
- BAX 0.60
- MACD
- AES -0.06
- BAX 0.08
- Stochastic Oscillator
- AES 33.45
- BAX 63.49
About AES The AES Corporation
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.